End-stage renal disease in African-Americans - PubMed (original) (raw)
Review
. 2000 Dec;27(6):597-600.
Affiliations
- PMID: 16649339
Review
End-stage renal disease in African-Americans
C A Boone. Nephrol Nurs J. 2000 Dec.
Abstract
The African-American community comprises approximately 12.4% of the total American population, but they account for 30.8% of patients diagnosed with end stage renal disease (ESRD). This article focuses first on theories explaining the high prevalence of ESRD in African-Americans. Two major causes of ESRD, hypertension and Type II diabetes, and their relationship to African-Americans are explored. Morbidity, familial risk and new incidences are addressed. Lastly, a screening project for African-Americans at risk for ESRD is proposed.
Similar articles
- Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis.
Owen WF Jr. Owen WF Jr. Blood Purif. 1996;14(4):278-85. doi: 10.1159/000170274. Blood Purif. 1996. PMID: 8873953 - Lessons from chronic renal diseases in African Americans: treatment implications.
Agodoa L. Agodoa L. Ethn Dis. 2003 Summer;13(2 Suppl 2):S118-24. Ethn Dis. 2003. PMID: 13677426 - The familial risk of end-stage renal disease in African Americans.
Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr. Freedman BI, et al. Am J Kidney Dis. 1993 Apr;21(4):387-93. doi: 10.1016/s0272-6386(12)80266-6. Am J Kidney Dis. 1993. PMID: 8465818 - Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
Lopes AA. Lopes AA. Adv Ren Replace Ther. 2004 Jan;11(1):14-23. doi: 10.1053/j.arrt.2003.10.006. Adv Ren Replace Ther. 2004. PMID: 14730535 Review. - End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy.
Powers DR, Wallin JD. Powers DR, et al. Arch Intern Med. 1998 Apr 13;158(7):793-800. doi: 10.1001/archinte.158.7.793. Arch Intern Med. 1998. PMID: 9554686 Review.
Cited by
- Genetic susceptibility of hypertension-induced kidney disease.
Zhang C, Fang X, Zhang H, Gao W, Hsu HJ, Roman RJ, Fan F. Zhang C, et al. Physiol Rep. 2021 Jan;9(1):e14688. doi: 10.14814/phy2.14688. Physiol Rep. 2021. PMID: 33377622 Free PMC article. Review. - Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia.
Orlov SN, Gossard F, Pausova Z, Akimova OA, Tremblay J, Grim CE, Kotchen JM, Kotchen TA, Gaudet D, Cowley AW, Hamet P. Orlov SN, et al. Am J Hypertens. 2010 Mar;23(3):321-6. doi: 10.1038/ajh.2009.249. Epub 2009 Dec 31. Am J Hypertens. 2010. PMID: 20044742 Free PMC article. - Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans.
Leak TS, Perlegas PS, Smith SG, Keene KL, Hicks PJ, Langefeld CD, Mychaleckyj JC, Rich SS, Kirk JK, Freedman BI, Bowden DW, Sale MM. Leak TS, et al. Ann Hum Genet. 2009 Mar;73(2):152-9. doi: 10.1111/j.1469-1809.2008.00498.x. Epub 2009 Jan 23. Ann Hum Genet. 2009. PMID: 19183347 Free PMC article. - The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.
Lea JP, Norris K, Agodoa L. Lea JP, et al. Am J Nephrol. 2008;28(5):732-43. doi: 10.1159/000127981. Epub 2008 Apr 24. Am J Nephrol. 2008. PMID: 18434712 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical